Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference

Area of Science:

• Immunology
• Hematology
• Rare Diseases

Background:

• Mast cell disorders are rare, complex conditions requiring multidisciplinary expertise.
• A need exists for a dedicated network to connect researchers and clinicians in mast cell disease.
• Existing research efforts are fragmented, hindering progress in diagnosis and treatment.

Framework:

• The American Initiative in Mast Cell Diseases (AIM) was established to create a collaborative Pan-American organization.
• AIM aims to unite basic, translational, and clinical researchers, along with academic institutions and biopharmaceutical companies.
• The network will facilitate collaborations to advance diagnostic methods and therapeutic development.

Implementation:

• The inaugural AIM investigator conference convened in May 2019 at Stanford University.
• Selected topics discussed included mast cell biology, hereditary alpha-tryptasemia, mast cell activation syndromes, and mastocytosis.
• Discussions also covered allergy, anaphylaxis, and the heterogeneity of indolent mastocytosis.

Implications:

• AIM seeks to coordinate scientific efforts across the Americas and collaborate with European networks like the European Competence Network on Mastocytosis.
• The initiative will enhance the understanding of mast cell biology in health and disease.
• Ultimately, AIM aims to accelerate the development and testing of novel therapies for mast cell disorders.